During the past decade, UCLH Cancer Clinical Trials Unit conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UCLH Cancer Clinical Trials Unit" #1 sponsor was "Adaptimmune" with 1 trials, followed by "Celgene" with 1 trials sponsored, "Celgene Corporation" with 1 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored and "Verastem, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UCLH Cancer Clinical Trials Unit" #1 collaborator was "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator and "GOG Foundation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "UCLH Cancer Clinical Trials Unit" are "Colorectal Cancer" (1 trials), "Low Grade Ovarian Serous Adenocarcinoma" (1 trials), "Multiple Myeloma" (1 trials), "Myxoid Liposarcoma" (1 trials) and "Newly Diagnosed Multiple Myeloma" (1 trials). Many other conditions were trialed in "UCLH Cancer Clinical Trials Unit" in a lesser frequency.

Most popular intervention types in "UCLH Cancer Clinical Trials Unit" are "Drug" (4 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Aspirin" (1 trials), "CC-92480" (1 trials), "CS-7017" (1 trials) and "Dexamethasone" (1 trials). Other intervention names were less common.

The vast majority of trials in "UCLH Cancer Clinical Trials Unit" are 4 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "UCLH Cancer Clinical Trials Unit". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in UCLH Cancer Clinical Trials Unit, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in UCLH Cancer Clinical Trials Unit, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".